KLF5 and non-small cell lung carcinoma: Given that inhibiting KLF5 offers a potentially important therapeutic strategy to target CSCs 17, 51, the current study provides a new strategy that targets the α-Catulin-KLF5 complex to suppress CSCs in NSCLC.